Search Results 6831-6840 of 25404 for oral

  1. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Cancer Care at Mayo Clinic · Head and Neck Cancer Center · Oncology (Medical) · Oral and Maxillofacial Surgery · Oral ...

  2. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  3. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...

  4. Salivary gland tumors - Doctors and departments - Mayo Clinic

    Departments that treat this condition. Cancer Care at Mayo Clinic · Head and Neck Cancer Center · Oncology (Medical) · Oral and Maxillofacial Surgery · Oral ...

  5. PR3-AAV Resilient Remission or PRRR - Clinical Trials

    ... (oral, injectable, implant or ring); 3) barrier contraceptives (condom or diaphragm) with spermicide; or 4) abstinence. Exclusion Criteria: - Diagnosis with ...

  6. A Study to Compare the Effectiveness and Safety of Emixustat Hydrochloride with Placebo to Treat Macular Atrophy Secondary to Stargadt Disease - Mayo Clinic

    Able to reliably administer oral medication by self or with available assistance. Able and willing to provide written informed consent/assent. For subjects ...

  7. Living in the Present, Grateful for Life - Mayo Clinic News Network

    Kellie was prescribed anti-coagulant injections and oral blood thinners to treat the embolism. Her kidney tumors, which were unrelated to the breast cancer ...

  8. Robotic surgery - Doctors & Departments - Mayo Clinic

    ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer. Show more areas of focus for Eric J. Moore, M.D.. Adyr A ...

  9. Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients with Stage IV Melanoma that Cannot be Removed by Surgery - Mayo Clinic

    Ongoing need for full-dose oral or parenteral anticoagulation; Ongoing anti-platelet treatment other than low-dose aspirin (i.e., aspirin 81 mg by mouth ...

  10. Rituximab, Bendamustine Hydrochloride, and Lenalidomide in Treating Patients with Refractory or Relapsed Indolent Non-Hodgkin Lymphoma - Mayo Clinic

    Patients unable to take any prophylaxis are not eligible. Life expectancy ≥6 months; Ability to swallow oral medications. Exclusion Criteria: This study ...